Daniel M. Hartung

Reporting Discrepancies Between the ClinicalTrials.gov Results Database and Peer-Reviewed Publications

Daniel M. Hartung, Deborah A. Zarin, Jeanne‐Marie Guise et al. · Annals of Internal Medicine · 2014 · 230 citations

Common Inconsistency, Clinical Endpoint, Databases +17

Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs

Elaine H. Morrato, Benjamin G. Druss, Daniel M. Hartung et al. · Archives of General Psychiatry · 2010 · 198 citations

Metabolic Screening in Children Receiving Antipsychotic Drug Treatment

Elaine H. Morrato, Ginger E. Nicol, David M. Maahs et al. · Archives of Pediatrics and Adolescent Medicine · 2010 · 147 citations · Full text

Dynamic random projection for biometric template protection

Bian Yang, Daniel M. Hartung, Koen Simoens et al. · 2010 · 99 citations · Full text

Engineering, Random Projection, Biometric Privacy +18

Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden

Neda J. Kazerouni, Adriane N. Irwin, Ximena A. Levander et al. · Drug and Alcohol Dependence · 2021 · 96 citations

Opioid Epidemic, High Opioid, Substance Abuse +14